Trial Profile
A phase 1, randomized, double-blind, single-center, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetics of ascending multiple oral doses of XW10172 in healthy adult subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jun 2021
Price :
$35
*
At a glance
- Drugs Valiloxybate (Primary)
- Indications Narcolepsy
- Focus Adverse reactions
- Sponsors XW labs; XWPharma
- 14 Jun 2021 Results published in the XWPharma Media Release.
- 14 Jun 2021 According to a XWPharma media release, data from the study were presented at the virtual SLEEP 2021, the annual meeting of the Associated Professional Sleep Societies.
- 26 Jun 2019 Status changed from not yet recruiting to completed.